Literature DB >> 19515275

A controlled trial of antidepressants in patients with Parkinson's disease and depression.

John C Morgan1, Kapil D Menza.   

Abstract

Entities:  

Year:  2009        PMID： 19515275     DOI： 10.1007/s11910-009-0038-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  7 in total

1.  Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life.

Authors:  Angelo Antonini; Silvana Tesei; Anna Zecchinelli; Paolo Barone; Danilo De Gaspari; Margherita Canesi; Giorgio Sacilotto; Nicoletta Meucci; Claudio Mariani; Gianni Pezzoli
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

Review 2.  Quality of life and depression in Parkinson's disease.

Authors:  Anette Schrag
Journal:  J Neurol Sci       Date:  2006-06-21       Impact factor: 3.181

3.  Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J M Miyasaki; K Shannon; V Voon; B Ravina; G Kleiner-Fisman; K Anderson; L M Shulman; G Gronseth; W J Weiner
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

4.  Depression is associated with impairment of ADL, not motor function in Parkinson disease.

Authors:  Suzanne Holroyd; Lillian J Currie; G Frederick Wooten
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

5.  A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group.

Authors:  I H Richard; R Kurlan
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

Review 6.  A systematic review of prevalence studies of depression in Parkinson's disease.

Authors:  Jennifer S A M Reijnders; Uwe Ehrt; Wim E J Weber; Dag Aarsland; Albert F G Leentjens
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

7.  Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.

Authors:  David Devos; Kathy Dujardin; Isabelle Poirot; Caroline Moreau; Olivier Cottencin; Pierre Thomas; Alain Destée; Regis Bordet; Luc Defebvre
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338
  7 in total
  1 in total

Review 1.  Depression in multiple system atrophy: Views on pathological, clinical and imaging aspects.

Authors:  Qiuyi Lv; Yuxin Pan; Xing Chen; Jingpei Wei; Wei Wang; Hua Zhang; Jifeng Wan; Shiqiang Li; Yan Zhuang; Baolin Yang; Dayong Ma; Dawei Ren; Zijun Zhao
Journal:  Front Psychiatry       Date:  2022-09-08       Impact factor: 5.435
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.